Tavexia Lifecare shines on expanding into pharmaceutical business
Tavexia Lifecare is currently trading at Rs. 1.05, up by 0.17 points or 19.32% from its previous closing of Rs. 0.88 on the BSE.
The scrip opened at Rs. 0.92 and has touched a high and low of Rs. 1.05 and Rs. 0.92 respectively. So far 6076459 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 1.05 on 26-Aug-2026 and a 52 week low of Rs. 0.49 on 04-Dec-2025.
Last one week high and low of the scrip stood at Rs. 1.05 and Rs. 0.74 respectively. The current market cap of the company is Rs. 40.28 crore.
The promoters holding in the company stood at 6.39%, while non-institutions held 93.61% stake in the company.
Tavexia Lifecare has expanded into the pharmaceutical business as an additional growth vertical, strengthening its broader presence in the healthcare and lifecare ecosystem. The move forms part of the company’s growth and diversification strategy while its existing lifecare business remains at the core of its operations.
The company plans to explore opportunities across the pharmaceutical value chain, including pharmaceutical products, active pharmaceutical ingredients (APIs), intermediates, specialty chemicals, nutraceuticals and related manufacturing opportunities. The new vertical is intended to complement Tavexia’s existing lifecare operations and provide additional avenues for business expansion.
